Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom.
Ashvin KuriBenjamin Meir JacobsNikki VickaryousJulia PakpoorJaap MiddeldorpGavin GiovannoniChu-Yueh GuoPublished in: BMC public health (2020)
We report that overall EBV seroprevalence in the UK appears to have increased, and that a sharp increase in EBV seropositivity is seen in adolescent females, but not males. The incidence of IM requiring hospitalisation is increasing. Exposures associated with prevalent IM in a diverse population include white ethnicity, lower BMI, and never-smoking, and these exposures interact with each other. Lastly, we provide pilot evidence suggesting that antibody responses to vaccine and commonly encountered pathogens do not appear to be diminished among EBV-seronegative individuals. Our findings could help to inform vaccine study designs in efforts to prevent IM and late complications of EBV infection, such as Multiple Sclerosis.